Clinical Trial Update: Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating adherence-improving fixed-dose combination therapy of Olostar in patients with hypertension and dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias
• Hypertension

Drugs mentioned

• Olostar

Snippet

Sponsor: Yonsei University | Conditions: Hypertension, Dyslipidemias | Phase 4 | Status: COMPLETED